AUG 11, 2026 · JOURNAL ARTICLE
Weight and Glycemic Outcomes Following GLP-1 Receptor Agonist Therapy in People Living with HIV: A Retrospective Study at a Bronx Hospital
Diabetology
Retrospective single-centre study with modest effect sizes (1.0% HbA1c reduction, 3.55% weight loss) in a defined population; real findings needing prospective confirmation in larger cohorts.
Reported
Sample size202
Mean duration of therapy24.2 months
Mean HbA1c reduction1.0%